logo

Dermapharm | Sustainability & Chart

DE000A2GS5D8

Basic information on Dermapharm

Location: Germany

Industry: Manufacturing

Website

knob-globe
51%

Impact Score

Description Dermapharm

Dermapharm is a German pharmaceutical company focusing on the manufacturing and distribution of patent-free drugs and health products.

Dermapharm Sustainability Performance

Renewable Energy
Greenhouse Gas Emissions
Supply Chain
Waste Recycling
Sustainable [100]
Almost sustainable [67-99]
Moderate [34-66]
Not sustainable [0-33]
No data
We measure the sustainability of companies based on 12 criteria.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). Learn more about our method.

Compare Dermapharm with ...

Dermapharm

?

Impact Score

knob-globe
51%
knob-globe
0%
Climate
Society
Gender

Sources of sustainability performance

MetricValueUnitYearPDF NamePDF Page
CEO Pay Ratio
CEO salary1 428€k2025DERMAPHARM_FY_2025_ANNUAL_REPORT.pdf176
Number of employees3 454people2025DERMAPHARM_FY_2025_NON-FINANCIAL_GROUP_REPORT.pdf38
CEO nameDr Hans-Georg Feldmeier2025DERMAPHARM_FY_2025_ANNUAL_REPORT.pdf20
Total wages paid291 571EUR thousand2025DERMAPHARM_FY_2025_ANNUAL_REPORT.pdf143
Employee Turnover Rate
Employee turnover10,01rate2025DERMAPHARM_FY_2025_NON-FINANCIAL_GROUP_REPORT.pdf39
Glass Ceiling
People in management164people2025DERMAPHARM_FY_2025_NON-FINANCIAL_GROUP_REPORT.pdf39
Number of employees3 454people2025DERMAPHARM_FY_2025_NON-FINANCIAL_GROUP_REPORT.pdf38
Women in workforce2 013people2025DERMAPHARM_FY_2025_NON-FINANCIAL_GROUP_REPORT.pdf38
Women in management78female2025DERMAPHARM_FY_2025_NON-FINANCIAL_GROUP_REPORT.pdf39
Greenhouse Gas Emissions
Scope 2 emissions, location based9 647t CO2e2025DERMAPHARM_FY_2025_NON-FINANCIAL_GROUP_REPORT.pdf28
Scope 1 emissions13 310t CO2e2025DERMAPHARM_FY_2025_NON-FINANCIAL_GROUP_REPORT.pdf28
Number of employees3 454people2025DERMAPHARM_FY_2025_NON-FINANCIAL_GROUP_REPORT.pdf38
Harassment and Discrimination at the Workplace
Anti-discrimination policyYes2025DERMAPHARM_FY_2025_ANNUAL_REPORT.pdf67
Confidentiality mechanismsYes2025Code_of_Conduct_of_the_Dermapharm_Group.pdf5
Incident notification mechanismYes2025DERMAPHARM_FY_2025_NON-FINANCIAL_GROUP_REPORT.pdf49
Retaliation safeguardsYes2025DERMAPHARM_FY_2025_NON-FINANCIAL_GROUP_REPORT.pdf49
Renewable Energy
Total renewable energy consumption26%2025DERMAPHARM_FY_2025_NON-FINANCIAL_GROUP_REPORT.pdf26
Supply Chain
Scope 1 emissions13 310t CO2e2025DERMAPHARM_FY_2025_NON-FINANCIAL_GROUP_REPORT.pdf28
Scope 2 emissions, location based9 647t CO2e2025DERMAPHARM_FY_2025_NON-FINANCIAL_GROUP_REPORT.pdf28
Number of employees3 454people2025DERMAPHARM_FY_2025_NON-FINANCIAL_GROUP_REPORT.pdf38
Scope 3 emissions267 594t CO2e2025DERMAPHARM_FY_2025_NON-FINANCIAL_GROUP_REPORT.pdf28
Union Formation and Collective Bargaining Power
Collective bargaining agreements coverage13,6%2023DERMAPHARM_CSR-Bericht2023_en_locked.pdf41
Women on Board
Executive board size3people2025DERMAPHARM_FY_2025_ANNUAL_REPORT.pdf22
Women on executive board0Members2025DERMAPHARM_FY_2025_ANNUAL_REPORT.pdf22
Supervisory board size3people2025DERMAPHARM_FY_2025_NON-FINANCIAL_GROUP_REPORT.pdf8
Women on supervisory board0people2025DERMAPHARM_FY_2025_NON-FINANCIAL_GROUP_REPORT.pdf8
Women in Management
People in management164people2025DERMAPHARM_FY_2025_NON-FINANCIAL_GROUP_REPORT.pdf39
Women in management78female2025DERMAPHARM_FY_2025_NON-FINANCIAL_GROUP_REPORT.pdf39
Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.

Find more sustainable companies

logo
© 2026 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The source of ETF data is the websites and data sheets of the respective ETF providers.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support!Logos provided by Logo.dev